Decreased serum thymic factor activity in asthmatic children. 1978

E Garaci, and R Ronchetti, and V Del Gobbo, and G Tramutoli, and C Rinaldi-Garaci, and C Imperato

Serum thymic factor (STF) activity was assayed in 26 young asthmatic patients and in 20 age-and sex-matched controls, in view of the increasing importance attributed to this thymic product in regulating several immune mechanisms. Determinations of total and specific IgE and of other immunoglobulins and skin tests were also performed. Decreased STF activity and high total and specific IgE concentrations were observed in the majority of asthmatic patients. In controls, STF activity was within normal limits in all cases and total and specific IgE concentrations were increased only on one case. The decreased STF activity may be responsible for a possible impairment of cell-mediated immunity and for the increased stimulation of the reaginic system observed in asthmatic patients, via its effects on some T cell subpopulation, namely, suppressor T lymphocytes, which seem particularly sensitive to STF variations. On the basis of these data and of the results of our study, a possible, although speculative, correlation between reduced STF activity and high IgE concentrations in asthmatic patients may be postulated. The reported increased occurrence of autoimmune phenomena in asthmatic patients is in agreement with the hypothesis of a STF-mediated suppressor T-lymphocyte quantitative and/or qualitative defect in this disease.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

E Garaci, and R Ronchetti, and V Del Gobbo, and G Tramutoli, and C Rinaldi-Garaci, and C Imperato
December 1984, The International journal of pediatric nephrology,
E Garaci, and R Ronchetti, and V Del Gobbo, and G Tramutoli, and C Rinaldi-Garaci, and C Imperato
November 2012, Clinical immunology (Orlando, Fla.),
E Garaci, and R Ronchetti, and V Del Gobbo, and G Tramutoli, and C Rinaldi-Garaci, and C Imperato
January 1985, Archivos de investigacion medica,
E Garaci, and R Ronchetti, and V Del Gobbo, and G Tramutoli, and C Rinaldi-Garaci, and C Imperato
October 1982, Comptes rendus des seances de l'Academie des sciences. Serie III, Sciences de la vie,
E Garaci, and R Ronchetti, and V Del Gobbo, and G Tramutoli, and C Rinaldi-Garaci, and C Imperato
February 1983, International journal of peptide and protein research,
E Garaci, and R Ronchetti, and V Del Gobbo, and G Tramutoli, and C Rinaldi-Garaci, and C Imperato
June 1982, Clinical immunology and immunopathology,
E Garaci, and R Ronchetti, and V Del Gobbo, and G Tramutoli, and C Rinaldi-Garaci, and C Imperato
March 1978, Nature,
E Garaci, and R Ronchetti, and V Del Gobbo, and G Tramutoli, and C Rinaldi-Garaci, and C Imperato
January 1966, International archives of allergy and applied immunology,
E Garaci, and R Ronchetti, and V Del Gobbo, and G Tramutoli, and C Rinaldi-Garaci, and C Imperato
June 1981, FEBS letters,
E Garaci, and R Ronchetti, and V Del Gobbo, and G Tramutoli, and C Rinaldi-Garaci, and C Imperato
January 1984, Archivos de investigacion medica,
Copied contents to your clipboard!